PT Metro Healthcare Indonesia Tbk (IDX:CARE)
Indonesia · Delayed Price · Currency is IDR 450.00
-12.00 (-2.60%)
Feb 6, 2026, 4:00 PM WIB
IDX:CARE Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 315,902 | 319,022 | 242,681 | 260,426 | 290,934 | 216,296 | |
Revenue Growth (YoY) | 2.33% | 31.46% | -6.81% | -10.49% | 34.51% | 40.38% |
Cost of Revenue | 165,410 | 216,317 | 154,716 | 166,533 | 146,481 | 114,639 |
Gross Profit | 150,492 | 102,705 | 87,965 | 93,893 | 144,454 | 101,657 |
Selling, General & Admin | 116,212 | 124,842 | 115,939 | 145,618 | 120,302 | 111,011 |
Other Operating Expenses | 6,803 | 6,512 | 7,782 | 8,663 | 8,748 | 3,569 |
Operating Expenses | 123,775 | 132,633 | 124,104 | 154,484 | 130,356 | 117,174 |
Operating Income | 26,717 | -29,928 | -36,139 | -60,591 | 14,098 | -15,517 |
Interest Expense | -70,481 | -74,565 | -75,775 | -89,333 | -25,432 | -11,306 |
Interest & Investment Income | 7,012 | 6,243 | 6,623 | 31,785 | 15,782 | 40,428 |
Other Non Operating Income (Expenses) | 16,313 | -961.36 | -904.24 | -844.92 | -694.16 | 187.68 |
EBT Excluding Unusual Items | -20,439 | -99,212 | -106,195 | -118,984 | 3,754 | 13,793 |
Gain (Loss) on Sale of Assets | 15,763 | 23,448 | 72 | 25,668 | 76.36 | - |
Other Unusual Items | - | - | - | - | 2,676 | - |
Pretax Income | -4,676 | -75,764 | -106,123 | -93,316 | 6,507 | 13,793 |
Income Tax Expense | 3,570 | 4,153 | 4,566 | 288.46 | 332.91 | -375.14 |
Earnings From Continuing Operations | -8,246 | -79,917 | -110,689 | -93,604 | 6,174 | 14,168 |
Minority Interest in Earnings | -351.45 | -391.96 | -230.93 | 60.53 | -74.43 | 144.89 |
Net Income | -8,597 | -80,309 | -110,920 | -93,544 | 6,099 | 14,313 |
Net Income to Common | -8,597 | -80,309 | -110,920 | -93,544 | 6,099 | 14,313 |
Net Income Growth | - | - | - | - | -57.39% | - |
Shares Outstanding (Basic) | 33,250 | 33,250 | 33,250 | 33,250 | 33,250 | 28,250 |
Shares Outstanding (Diluted) | 33,250 | 33,250 | 33,250 | 33,250 | 33,250 | 28,250 |
Shares Change (YoY) | - | - | - | - | 17.70% | 264.44% |
EPS (Basic) | -0.26 | -2.42 | -3.34 | -2.81 | 0.18 | 0.51 |
EPS (Diluted) | -0.26 | -2.42 | -3.34 | -2.81 | 0.18 | 0.51 |
EPS Growth | - | - | - | - | -63.80% | - |
Free Cash Flow | -196,720 | -339,941 | -95,595 | -339,291 | -263,276 | -471,965 |
Free Cash Flow Per Share | -5.92 | -10.22 | -2.88 | -10.20 | -7.92 | -16.71 |
Gross Margin | 47.64% | 32.19% | 36.25% | 36.05% | 49.65% | 47.00% |
Operating Margin | 8.46% | -9.38% | -14.89% | -23.27% | 4.85% | -7.17% |
Profit Margin | -2.72% | -25.17% | -45.71% | -35.92% | 2.10% | 6.62% |
Free Cash Flow Margin | -62.27% | -106.56% | -39.39% | -130.28% | -90.49% | -218.20% |
EBITDA | 51,515 | -4,412 | -14,554 | -37,714 | 31,395 | -3,398 |
EBITDA Margin | 16.31% | -1.38% | -6.00% | -14.48% | 10.79% | -1.57% |
D&A For EBITDA | 24,798 | 25,516 | 21,585 | 22,878 | 17,297 | 12,119 |
EBIT | 26,717 | -29,928 | -36,139 | -60,591 | 14,098 | -15,517 |
EBIT Margin | 8.46% | -9.38% | -14.89% | -23.27% | 4.85% | -7.17% |
Effective Tax Rate | - | - | - | - | 5.12% | - |
Advertising Expenses | - | 490.32 | 332.36 | 621.1 | 204.18 | - |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.